Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.3101 USD | -6.71% |
|
+49.66% | -43.62% |
15/07 | Qualigen Therapeutics, Inc. Announces Board Changes | CI |
08/07 | Qualigen Therapeutics, Inc. announced that it has received $2 million in funding | CI |
Sales 2022 | 4.98M 417M | Sales 2023 | - | Capitalization | 2.85M 238M |
---|---|---|---|---|---|
Net income 2022 | -18M -1.5B | Net income 2023 | -13M -1.09B | EV / Sales 2022 | 0.19 x |
Net cash position 2022 | 4.48M 375M | Net Debt 2023 | 897K 75.03M | EV / Sales 2023 | - |
P/E ratio 2022 |
-0.27
x | P/E ratio 2023 |
-0.21
x | Employees | 4 |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 94.02% |
1 day | -6.71% | ||
1 week | +49.66% | ||
Current month | +79.98% | ||
1 month | +77.40% | ||
3 months | +4.27% | ||
6 months | -39.79% | ||
Current year | -43.62% |
![Extreme 0.2851](/images/extremecours_fleche.png)
![Extreme 0.1525](/images/extremecours_fleche.png)
![Extreme 0.1449](/images/extremecours_fleche.png)
![Extreme 0.1449](/images/extremecours_fleche.png)
![Extreme 0.1449](/images/extremecours_fleche.png)
![Extreme 0.1449](/images/extremecours_fleche.png)
![Extreme 0.1449](/images/extremecours_fleche.png)
Managers | Title | Age | Since |
---|---|---|---|
Michael Poirier
CEO | Chief Executive Officer | 68 | 01/20/01 |
Christopher Lotz
DFI | Director of Finance/CFO | 59 | 01/02/01 |
Members of the board | Title | Age | Since |
---|---|---|---|
Michael Poirier
CEO | Chief Executive Officer | 68 | 01/20/01 |
Director/Board Member | 49 | 01/20/01 |
Date | Price | Change | Volume |
---|---|---|---|
17/24/17 | 0.3101 | -6.71% | 2,185,382 |
16/24/16 | 0.3324 | -14.04% | 4,325,215 |
15/24/15 | 0.3867 | -10.92% | 20,020,586 |
12/24/12 | 0.4341 | +111.45% | 420,237,352 |
11/24/11 | 0.2053 | -0.92% | 709,605 |
Delayed Quote Nasdaq, July 18, 2024 at 01:30 am IST
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-43.62% | 3.77M | |
+24.74% | 47.54B | |
-0.47% | 41.96B | |
+48.77% | 41.55B | |
+25.40% | 30.36B | |
+17.96% | 27.61B | |
-4.47% | 28.7B | |
+50.73% | 14.7B | |
+42.56% | 13.51B | |
+1.46% | 12.34B |
- Stock Market
- Equities
- QLGN Stock